Finding solutions that improve patients’ lives
We aim to deliver major therapeutic advances by treating patients with a high burden of disease, offering clear benefits for patients and sound health economics for society. Our exciting R&D pipeline includes several new drug candidates and technologies to improve patients’ lives.
At Grünenthal, there is close collaboration between all stakeholders involved in research, and each is equally important. Our networked approach to R&D means that we can interlink and supplement our own expertise with external knowledge, leading to improved outcomes.